The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Open accessAbstract
Aims/hypothesisAldosterone concentrations increase in obesity and predict the onset of diabetes. We investigated the effects of aldosterone on glucose homeostasis and insulin secretion in vivo and in vitro.MethodsWe assessed insulin sensitivity and insulin secretion in aldosterone synthase-deficient (As [also known as Cyp11b2]−/−) and wild-type mice using euglycaemic–hyperinsulinaemic and hyperglycaemic clamps, respectively. We also conducted studies during high sodium intake to normalise renin activity and potassium concentration in As−/− mice. We subsequently assessed the effect of aldosterone on insulin secretion in vitro in the presence or absence of mineralocorticoid receptor antagonists in isolated C57BL/6J islets and in the MIN6 beta cell line.ResultsFasting glucose concentrations were reduced in As−/− mice compared with wild-type. During hyperglycaemic clamps, insulin and C-peptide concentrations increased to a greater extent in As−/− than in wild-type mice. This was not attributable to differences in potassium or angiotensin II, as glucose-stimulated insulin secretion was enhanced in As−/− mice even during high sodium intake. There was no difference in insulin sensitivity between As−/− and wild-type mice in euglycaemic–hyperinsulinaemic clamp studies. In islet and MIN6 beta cell studies, aldosterone inhibited glucose- and isobutylmethylxanthine-stimulated insulin secretion, an effect that was not blocked by mineralocorticoid receptor antagonism, but was prevented by the superoxide dismutase mimetic tempol.Conclusions/interpretationWe demonstrated that aldosterone deficiency or excess modulates insulin secretion in vivo and in vitro via reactive oxygen species and in a manner that is independent of mineralocorticoid receptors. These findings provide insight into the mechanism of glucose intolerance in conditions of relative aldosterone excess.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We recently demonstrated that aldosterone directly impairs insulin secretion in isolated murine pancreatic islets”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“genetic aldosterone deficiency markedly increases insulin secretion in mice (6, 7)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“aldosterone deficiency in mice increases insulin secretion in vivo without altering insulin sensitivity (6).”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Aldosterone impairs insulin secretion in isolated rodent islets and insulinoma cell lines”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y., & Yamamura, K. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,267
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
Tuck, M. L., Sowers, J. R., Dornfeld, L., Kledzik, G. S., & Maxwell, M. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104163041602 · Cited by 643
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R., Stier, C. T., Kifor, I., Ochoa-Maya, M. R., Rennke, H. G., Williams, G. H., & Adler, G. K. (2000) · Endocrinology · doi:10.1210/endo.141.10.7711 · Cited by 480
McMurray, J. J. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0909392 · Cited by 464
Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Ayala, J. E., Bracy, D. P., McGuinness, O. P., & Wasserman, D. H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0686 · Cited by 406
Self-citationReduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Briššová, M., Shiota, M., Nicholson, W. E., GANNON, M. A., Knobel, S. M., Piston, D. W., Wright, C. V. E., & Powers, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111272200 · Cited by 376
Self-citationAldosterone: effects on the kidney and cardiovascular system
Briet, M. B., & Schiffrin, E. L. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.30 · Cited by 346
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
Hypertension, the Potassium Ion and Impaired Carbohydrate Tolerance
Conn, J. W. (1965) · New England Journal of Medicine · doi:10.1056/nejm196511182732106 · Cited by 329
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315
Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats
Carlsson, P., Berne, C., & Jansson, L. E. (1998) · Diabetologia · doi:10.1007/s001250050880 · Cited by 305
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Scheen, A. J. (2004) · Drugs · doi:10.2165/00003495-200464220-00004 · Cited by 293
Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains
Berglund, E. D., Li, C. Y., Poffenberger, G., Ayala, J. E., Fueger, P. T., Willis, S. E., Jewell, M. M., Powers, A. C., & Wasserman, D. H. (2008) · Diabetes · doi:10.2337/db07-1615 · Cited by 265
Self-citationInsulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Plasma aldosterone is independently associated with the metabolic syndrome
Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231338.41548.fc · Cited by 226
Aldosterone Synthase Inhibition With LCI699
Amar, L., Azizi, M., Ménard, J., Peyrard, S., Watson, C. E., & Plouin, P. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 208
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205
Ingelsson, E., Pencina, M. J., Tofler, G. H., Benjamin, E. J., Lanier, K. J., Jacques, P. F., Fox, C. S., Meigs, J. B., Levy, D. A., Larson, M. G., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708537 · Cited by 195
The evolution of aldosterone antagonists
Garthwaite, S. M., & McMahon, E. G. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.005 · Cited by 192
Development of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor
Gómez-Sánchez, C. E., de Rodriguez, A. F., Romero, D. G., Estess, J., Warden, M. P., Gomez-Sanchez, M. T., & Gómez-Sánchez, E. P. (2005) · Endocrinology · doi:10.1210/en.2005-0860 · Cited by 182
Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000071081.35693.9a · Cited by 159
Self-citationColussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Hitomi, H., Kiyomoto, H., Nishiyama, A., Hara, T., Moriwaki, K., Kaifu, K., Ihara, G., Fujita, Y., Ugawa, T., & Kohno, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093955 · Cited by 140
β-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 129
Lastra, G., Whaley-Connell, A., Manrique, C., Habibi, J., Gutweiler, A. A., Appesh, L., Hayden, M. R., Wei, Y., Ferrario, C., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2007 · Cited by 119
Effects of eplerenone versus losartan in patients with low-renin hypertension
Weinberger, M. H., White, W. B., Ruilope, L. M., MacDonald, T. M., Davidson, R. C., Roniker, B., Patrick, J. L., & Krause, S. L. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.005 · Cited by 115
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80020-9 · Cited by 105
Expression and localization of the renin-angiotensin system in the rat pancreas
Leung, P. S., Chan, W., Wong, T. P., & Sernia, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600013 · Cited by 99
Homeostatic Responses in the Adrenal Cortex to the Absence of Aldosterone in Mice
Lee, G., Makhanova, N., Caron, K. M., Sequeira-Lόpez, M. L. S., Gómez, R. A., Smithies, O., & Kim, H. (2005) · Endocrinology · doi:10.1210/en.2004-1102 · Cited by 95
Self-citationA possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94
Lemarié, C. A., Simeone, S., Nikonova, A. S., Ebrahimian, T., Deschênes, M.-E., Coffman, T. M., Paradis, P., & Schiffrin, E. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.196576 · Cited by 92
Hirasawa, G., Sasano, H., Takahashi, K.-I., Fukushima, K., Suzuki, T., Hiwatashi, N., Toyota, T., Krozowski, Z. S., & Nagura, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4337 · Cited by 85
Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?
Gekle, M., & Großmann, C. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0616-0 · Cited by 80
Swaminathan, K., Davies, J. I., Casella, G., Rajendra, N. S., Morris, A. D., & Struthers, A. D. (2008) · Diabetologia · doi:10.1007/s00125-008-0972-5 · Cited by 78
Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment
Šindelka, G., Widimsky, J., Jr., Haas, T., Prázný, M., Hilgertová, J., & Škrha, J. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1329211 · Cited by 74
Kidney function in mice lacking aldosterone
Makhanova, N., Lee, G., Takahashi, N., Sequeira-Lόpez, M. L. S., Gómez, R. A., Kim, H., & Smithies, O. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00257.2005 · Cited by 71
Self-citationEffect of adrenal steroids on insulin release from cultured rat islets of Langerhans
Pierluissi, J., Navas, F. O., & Ashcroft, S. J. H. (1986) · Diabetologia · doi:10.1007/bf00456122 · Cited by 66
Research Resource: Nuclear Hormone Receptor Expression in the Endocrine Pancreas
Chuang, J.-C., Cha, J.-Y., Garmey, J. C., Mirmira, R. G., & J., J. J. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0568 · Cited by 61
Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?
Shimamoto, K., Shiiki, M., Ise, T., Miyazaki, Y., Higashiura, K., Fukuoka, M., Hirata, A., Masuda, A., Nakagawa, M., & Iimura, O. (1994) · PubMed · Cited by 50
Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Štrauch, B., Widimsky, J., Jr., Šindelka, G., & Škrha, J. (2003) · Physiological Research · doi:10.33549/physiolres.930298 · Cited by 44
Fueger, P. T., Hess, H. S., Bracy, D. P., Pencek, R., Posey, K. A., Charron, M. J., & Wasserman, D. H. (2004) · Endocrinology · doi:10.1210/en.2004-0465 · Cited by 41
Self-citationNon-genomic actions of aldosterone: mechanisms and consequences in kidney cells
Boldyreff, B. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg265 · Cited by 37
Energy Metabolism in Human Renin-Gene Transgenic Rats
Gratze, P., Boschmann, M., Dechend, R., Qadri, F., Malchow, J., Graeske, S., Engeli, S., Janke, J., Springer, J., Contrepas, A., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124966 · Cited by 33
Rapid effects of aldosterone on vascular cells: clinical implications
Lösel, R. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.005 · Cited by 29
Hirasawa, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3859 · Cited by 25
Luther, J. M., Wang, Z., Ma, J., Makhanova, N., Kim, H., & Brown, N. J. (2008) · Endocrinology · doi:10.1210/en.2008-1296 · Cited by 21
Self-citationLate-onset obesity in mice transgenic for the human renin gene
Uehara, S., Tsuchida, M., Kanno, T., Sasaki, M., Nishikibe, M., & Fukamizu, A. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.6.723 · Cited by 20
Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21572 · Cited by 8
Successful treatment of renovascular hypertension has no effect on insulin sensitivity
Voiculescu, A., Hollenbeck, M., Kutkuhn, B., Grabensee, B., & Plum, J. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01236.x · Cited by 2
Cited by
Sorted by citations
Jaisser, F., & Farman, N. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 348
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
UNDERWOOD, P. C., & Adler, G. K. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 219
Zhou, M.-S., Schulman, I. H., & Zeng, Q. (2012) · Vascular Medicine · doi:10.1177/1358863x12450094 · Cited by 214
The renin–angiotensin–aldosterone system and glucose homeostasis
Luther, J. M., & Brown, N. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.006 · Cited by 185
Self-citationHanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Metadata
- Authors
- Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J.
- Affiliations
- Vanderbilt University Medical Center (US)
- University of Tennessee Health Science Center (US)
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- VA Tennessee Valley Healthcare System (US)
- Corresponding author
- Luther, J. M.
- Venue
- Diabetologia
- Published
- 2011-04-26
- Volume
- 54
- Issue
- 8
- Pages
- 2152-2163
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3216479
- OpenAlex
- W1986937962
- Semantic Scholar
- a0c1e95c299c0afa3836d90ecaf36d72f7b3fc26
- Cited by
- 109
- References
- 52
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 9 · 2014: 4 · 2013: 10 · 2012: 11
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000666)
- Juvenile Diabetes Research Foundation International
- Vanderbilt University (DK59637, DK20593)
- National Institutes of Health (DK-59637, DK 20593, DK66636)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Heart, Lung, and Blood Institute (R01HL060906, R01HL067308, HL060906, HL07738, HL067308)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK68854, K23DK081662, R01DK068764, DK089572, U01DK089572, DK69603, DK66636, DK59637, R21DK066636, R21DK068854, DK072473, DK 20593, U24DK059637, DK081662, R01DK069603, R33DK066636, U01DK072473, P30DK020593)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone, glucose-stimulated insulin secretion, aldosterone synthase deficiency, CYP11B2, mineralocorticoid receptor, reactive oxygen species, tempol, pancreatic beta cells, insulin sensitivity, impaired glucose tolerance, obesity, diabetes mellitus, sodium intake, renin-angiotensin system, islets
- MeSH terms
- Insulin Secretion, Aldosterone, Animals, Blood Glucose, Cell Line, Glucose, Insulin, Islets of Langerhans, Male, Mice, Inbred C57BL, Cytochrome P-450 CYP11B2, Insulin-Secreting Cells, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
